🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
45.14
-2.18 (-4.61%)
Nov 20, 2026, 5:29 PM CET

Hansa Biopharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-785.37-534.11-807.24-831.72-611.13-548.28
Depreciation & Amortization
27.1610.3210.0910.749.966.51
Other Amortization
28.4428.4417.989.052.092.09
Asset Writedown & Restructuring Costs
9.53-----
Stock-Based Compensation
27.7934.7931.6960.6458.2356.62
Other Operating Activities
223.99-51136.64-15.816.69-1
Change in Accounts Receivable
-10.07-35.16-66.94-35.07-33.25-9.6
Change in Accounts Payable
11.5216.44-49.3524.499.1228.58
Change in Other Net Operating Assets
-131.71-18.8952.2622.0145.56-16.09
Operating Cash Flow
495.86-549.17-674.88-755.65-502.73-481.17
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.13--0.12-0.28-3.33-2.4
Sale (Purchase) of Intangibles
1.72-----
Investment in Securities
----232.64-
Investing Cash Flow
1.59--0.12-0.28229.31-2.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----736.4-
Long-Term Debt Repaid
--17.64-7.5-7.55-6.89-4.86
Lease Payments
-9.43-8.11-7.5-7.55-6.89-4.86
Net Debt Issued (Repaid)
-32.67-17.64-7.5-7.55729.51-4.86
Issuance of Common Stock
685.11903.6372.15-415.95-
Other Financing Activities
-66.79-38-17.85--27.78-
Financing Cash Flow
585.65847.96346.81-7.551,118-4.86

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.92-2.991.42-0.640.580.4
Net Cash Flow
1,084295.8-326.78-764.12844.84-488.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
495.73-549.17-675-755.94-506.06-483.57
Free Cash Flow Growth
------
Free Cash Flow Margin
164.34%-247.08%-394.01%-563.74%-327.50%-1427.38%
Free Cash Flow Per Share
4.87-6.76-10.74-14.39-11.27-10.87
Levered Free Cash Flow
90.4-345.68-423.66-438.91-282.34-257.8
Unlevered Free Cash Flow
210.62-269.12-339.86-372.96-255.05-257.36
Free Cash Flow After Leases
486.3-557.28-682.5-763.48-512.95-488.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----1.17-
Cash Income Tax Paid
-2.383.610.131.570.14
Change in Working Capital
964.33-37.61-64.0311.4421.432.89